Marc S Sabatine - JoVE Visualize

Showing results (111-120 of 481) with videos related to

Pageof 49

Sort By:

Clinical Chemistry|September 21, 2013

Prognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndromeErin A Bohula May, Marc P Bonaca, Petr Jarolim, et al.

Journal of the American Heart Association|May 22, 2016

Multimarker Risk Stratification in Patients With Acute Myocardial InfarctionMichelle L O'Donoghue, David A Morrow, Christopher P Cannon, et al.

Journal of the American College of Cardiology|March 3, 2012

Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular diseaseTracy Y Wang, Dominick J Angiolillo, Mary Cushman, et al.

Circulation|April 2, 2008

Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarctionMarc S Sabatine, David A Morrow, Luke J Higgins, et al.

Journal of the American College of Cardiology|November 26, 2002

Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial)substudyMarc S Sabatine, David A Morrow, Christopher P Cannon, et al.

Lancet (London, England)|September 1, 2009

Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trialMarc S Sabatine, Elliott M Antman, Petr Widimsky, et al.

American Heart Journal|June 7, 2011

Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22)Sean R Wilson, Marc S Sabatine, Stephen D Wiviott, et al.

Clinical Cardiology|January 24, 2014

Clinical implications and correlates of Q waves in patients with ST-elevation myocardial infarction treated with fibrinolysis: observations from the CLARITY-TIMI 28 trialJonathan W Waks, Marc S Sabatine, Christopher P Cannon, et al.

The American Journal of Cardiology|May 29, 2004

Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusionRobert P Giugliano, Marc S Sabatine, C Michael Gibson, et al.

Clinical Cardiology|June 18, 2022

Re-adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study-level meta-analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase-4 (DPP-4) inhibitorsBenjamin M Scirica, KyungAh Im, Sabina A Murphy, et al.

Pageof 49

Showing results (111-120 of 481) with videos related to

Sort By:

Pageof 49

Clinical Chemistry|September 21, 2013

Prognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndromeErin A Bohula May, Marc P Bonaca, Petr Jarolim, et al.

Journal of the American Heart Association|May 22, 2016

Multimarker Risk Stratification in Patients With Acute Myocardial InfarctionMichelle L O'Donoghue, David A Morrow, Christopher P Cannon, et al.

Journal of the American College of Cardiology|March 3, 2012

Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular diseaseTracy Y Wang, Dominick J Angiolillo, Mary Cushman, et al.

Circulation|April 2, 2008

Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarctionMarc S Sabatine, David A Morrow, Luke J Higgins, et al.

Journal of the American College of Cardiology|November 26, 2002

Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial)substudyMarc S Sabatine, David A Morrow, Christopher P Cannon, et al.

Lancet (London, England)|September 1, 2009

Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trialMarc S Sabatine, Elliott M Antman, Petr Widimsky, et al.

American Heart Journal|June 7, 2011

Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22)Sean R Wilson, Marc S Sabatine, Stephen D Wiviott, et al.

Clinical Cardiology|January 24, 2014

Clinical implications and correlates of Q waves in patients with ST-elevation myocardial infarction treated with fibrinolysis: observations from the CLARITY-TIMI 28 trialJonathan W Waks, Marc S Sabatine, Christopher P Cannon, et al.

The American Journal of Cardiology|May 29, 2004

Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusionRobert P Giugliano, Marc S Sabatine, C Michael Gibson, et al.

Clinical Cardiology|June 18, 2022

Re-adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study-level meta-analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase-4 (DPP-4) inhibitorsBenjamin M Scirica, KyungAh Im, Sabina A Murphy, et al.

Pageof 49